AFIB Acutus Medical
- 0.041
- -0.009-18.00%
Acutus Medical News
Acutus Medical | 10-Q: Quarterly report
Earnings Flash (AFIB) ACUTUS MEDICAL Posts Q1 Continuing Operations Revenue $3.6M
04:04 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (AFIB) ACUTUS MEDICAL Posts Q1 Continuing Operations Revenue $3.6M
Acutus Medical 1Q Rev $3.63M >AFIB
Acutus Medical 1Q Rev $3.63M >AFIB
Acutus Medical Delisted From Nasdaq Market Due to Non-compliance
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Upstart Holdings, Inc. (NASDAQ:UPST) fell sharply during Wednesday's session after the company reported first-quarter financial results and issued second-quarter revenue guidance below estim
Why RingCentral Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Shares of RingCentral, Inc. (NYSE:RNG) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results and raised its FY24 guidance.RingCentr
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersMonogram Orthopaedics (NASDAQ:MGRM) stock increased by 19.1% to $2.31 during Monday's pre-market session. The company's market cap stands at $73.1 million. Allarity Therapeutics (NASDAQ:ALLR) s
Acutus Medical, Inc. (AFIB) Faces Plummeting Stock Price Amid Delisting Concerns
Acutus Medical, Inc. (NASDAQ: AFIB) found itself in a downward spiral on Friday, with its stock price taking a significant hit during regular trading hours. Starting the day at $0.1540, AFIB closed at $0.1447, marking a nearly 6% decline. However, the real turmoil struck after the closing bell, as AFIB nosedived by almost 40% in ...
Acutus Medical Says Nasdaq Notified Co That It Has Not Regained Compliance With Listing Rule 5550(a)(2)
Acutus Medical Says Nasdaq Notified Co That It Has Not Regained Compliance With Listing Rule 5550(a)(2)
Earlier Announced, Acutus Medical Was Granted EU Patent #3294412 For "Localization System And Method Useful In The Acquisition And Analysis Of Cardiac Information".
Earlier Announced, Acutus Medical Was Granted EU Patent #3294412 For "Localization System And Method Useful In The Acquisition And Analysis Of Cardiac Information".
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersTrevena (NASDAQ:TRVN) shares increased by 27.0% to $0.51 during Wednesday's after-market session. The company's market cap stands at $9.2 million. Mustang Bio (NASDAQ:MBIO) stock increased by 1
Acutus Medical Full Year 2023 Earnings: US$0.41 Loss per Share (Vs US$1.40 Loss in FY 2022)
Acutus Medical GAAP EPS of -$2.81, Revenue of $7.2M
Acutus Medical 4Q Rev $2.4M >AFIB
Acutus Medical 4Q Rev $2.4M >AFIB
Acutus Medical: Due to Plan to Realign Resources to Support Left-Heart Access Distribution Business and Exit From Electrophysiology Mapping and Ablation Businesses, Co Will No Longer Provide Fincl Guidance >AFIB
Acutus Medical: Due to Plan to Realign Resources to Support Left-Heart Access Distribution Business and Exit From Electrophysiology Mapping and Ablation Businesses, Co Will No Longer Provide Fincl Gui
Press Release: Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results CARLSBAD, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB) today r
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersOntrak (NASDAQ:OTRK) shares increased by 97.6% to $0.38 during Tuesday's regular session. The market value of their outstanding shares is at $10.3 million. Fusion Pharmaceuticals (NASDAQ:FUSN)
Acutus Medical Has Been Granted European Patent Number EP3294412 Titled "Localization System And Method Useful In The Acquisition And Analysis Of Cardiac Information (For Diagnosis And Treatment Of Cardiac Abnormalities)".
Acutus Medical Has Been Granted European Patent Number EP3294412 Titled "Localization System And Method Useful In The Acquisition And Analysis Of Cardiac Information (For Diagnosis And Treatment Of Ca
It's Down 29% But Acutus Medical, Inc. (NASDAQ:AFIB) Could Be Riskier Than It Looks
Acutus Medical, Inc. (NASDAQ:AFIB) shareholders won't be pleased to see that the share price has had a very rough month, dropping 29% and undoing the prior period's positive performance.
Acutus Medical Has Been Granted European Patent Number EP3294399 Titled "Catheter System For Left Heart Access"
Acutus Medical Has Been Granted European Patent Number EP3294399 Titled "Catheter System For Left Heart Access"
Analysis
Price Target
No Data
